InVivoMAb Anti-Human ANGPTL3 Antibody (Iv0160) from ProteoGenix; catalogue ARO-A13203; research use only.
Know who made it. See the evidence. Buy through one marketplace.
InVivoMAb Anti-Human ANGPTL3 Antibody (Iv0160) is a ProteoGenix primary antibody supplied under catalogue number ARO-A13203 for research use only.
Target: ANG-5; Host: Human; Clonality: Monoclonal Antibody; Buffer: 0.01M PBS, pH 7.4.; Reactivity: Human.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
ANGPTL3 (angiopoietin like 3), also known as angiopoietin-related protein 3 and ANG-5, is a liver-enriched secreted protein studied for its control of lipoprotein lipase activity, triglyceride clearance and systemic lipid metabolism.
Biological function: ANGPTL3 is secreted predominantly by the liver and can be proteolytically processed into N- and C-terminal fragments. Reviewed UniProt evidence supports a hepatokine role in lipid and glucose metabolism; ANGPTL3 raises plasma triglycerides in part by inhibiting lipoprotein lipase (LPL), reducing triglyceride clearance. NCBI also describes distinct functional contributions of its N-terminal lipid-metabolism region and C-terminal fibrinogen-like region.
